Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
European Journal of Pediatrics|June 1, 1993
Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in childrenG Kanra, M Ceyhan, D Vandevoorde, et al.The Journal of Infectious Diseases|November 1, 1996
Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy childrenF Meurice, J L De Bouver, D Vandevoorde, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 1, 1995
Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 monthsA Ramkissoon, H M Coovadia, P Jugnundan, et al.Journal of Bacteriology|September 1, 1976
Septation deficiency and phosphilipid perturbation in Escherichia coli genetically constitutive for the beta oxidation pathwayE Vanderwinkel, M De Vlieghere, M Fontaine, et al.Vaccine|January 1, 1994
Study of pertussis vaccines in infants: comparison of response to acellular pertussis DTP vaccines containing 25 micrograms of FHA and either 25 or 8 micrograms of PT with response to whole-cell pertussis DTP vaccineH Vanura, M Just, F Ambrosch, et al.Materials and Structures|May 18, 2026
Quantifying sorptivity using the contact sponge method: an improved calculation method validated by classical capillary rise experiments and neutron radiographyH Derluyn, J Desarnaud, D Vandevoorde, et al.Vaccine|February 1, 1991
Development of an acellular pertussis vaccine and its administration as a booster in healthy adultsO Ruuskanen, A Noel, A Putto-Laurila, et al.The Pediatric Infectious Disease Journal|April 1, 1990
Measles, mumps and rubella immunization at nine months in a developing countryB D Schoub, S Johnson, J M McAnerney, et al.Pageof 1